Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.94% | $163.67M | €332.63B | 42.36% | 78 Outperform | |
| SAP SE | 2.12% | $117.65M | €251.69B | -2.01% | 73 Outperform | |
| HSBC Holdings | 1.88% | $104.53M | £183.91B | 55.75% | 79 Outperform | |
| Novartis AG | 1.81% | $100.41M | CHF194.13B | 9.79% | 78 Outperform | |
| Nestlé SA | 1.78% | $99.28M | CHF199.96B | 12.01% | 71 Outperform | |
| Roche Holding AG | 1.76% | $98.01M | CHF214.88B | 16.72% | 73 Outperform | |
| AstraZeneca | 1.73% | $96.43M | £199.98B | 31.46% | 76 Outperform | |
| Shell (UK) | 1.61% | $89.51M | £163.77B | 12.53% | 77 Outperform | |
| Siemens | 1.52% | $84.51M | €185.85B | 30.86% | 74 Outperform | |
| ― | 1.33% | $73.88M | ― | ― | ― |